BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23458598)

  • 21. Ethical issues in new drug prescribing.
    Cole LW; Kesselheim JC; Kesselheim AS
    J Bioeth Inq; 2012 Mar; 9(1):77-83. PubMed ID: 23180203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Conflicts of interest in clinical practice. Ethical analysis of some relationships with the pharmaceutical industry].
    Salas SP; Osorio F M; Vial C P; Rehbein V AM; Salas A C; Beca I JP
    Rev Med Chil; 2006 Dec; 134(12):1576-82. PubMed ID: 17277877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physician assistants for sale: will prescribe for food.
    Anderson J
    JAAPA; 2011 Aug; 24(8):57-8. PubMed ID: 21850922
    [No Abstract]   [Full Text] [Related]  

  • 24. The ethics of expediency.
    Glickel SZ
    J Hand Surg Am; 2009; 34(5):799-807. PubMed ID: 19410982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conflicts of interest in pain medicine: Practice patterns and relationships with industry.
    Schofferman J; Banja J
    Pain; 2008 Oct; 139(3):494-497. PubMed ID: 18814969
    [No Abstract]   [Full Text] [Related]  

  • 26. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
    De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
    PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician prescribing behavior and its impact on patient-level outcomes.
    Joyce GF; Carrera MP; Goldman DP; Sood N
    Am J Manag Care; 2011 Dec; 17(12):e462-71. PubMed ID: 22216870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clarifying the costs of conflicts of interest.
    Mayes C; Lipworth W; Kerridge I
    Int J Clin Pract; 2015 Mar; 69(3):384-5. PubMed ID: 25727803
    [No Abstract]   [Full Text] [Related]  

  • 29. No more free drug samples?
    Chimonas S; Kassirer JP
    PLoS Med; 2009 May; 6(5):e1000074. PubMed ID: 19434227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to clarifying the costs of conflicts of interest.
    Stossel TP; Barton DW; Stell LK
    Int J Clin Pract; 2015 Mar; 69(3):385-6. PubMed ID: 25727804
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharma "phree".
    Smith RP
    Obstet Gynecol; 2009 Jan; 113(1):152-153. PubMed ID: 19104371
    [No Abstract]   [Full Text] [Related]  

  • 32. Ethics for the pediatrician: physician interaction with the pharmaceutical industry.
    Cicero MX; Curi MB; Mercurio M
    Pediatr Rev; 2011 Jan; 32(1):e1-3. PubMed ID: 21196498
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug company sponsored symposia fulfil an important educational role.
    Collins IS
    Med J Aust; 2006 Dec 4-18; 185(11-12):673; author reply 674-5. PubMed ID: 17181523
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaism: a tale of two perspectives.
    Citrome L; Karagianis J; Maguire GA; Nierenberg AA
    Int J Clin Pract; 2014 Jun; 68(6):659-61. PubMed ID: 24837087
    [No Abstract]   [Full Text] [Related]  

  • 35. Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan.
    Saito H; Tani Y; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Tanimoto T
    Clin Microbiol Infect; 2019 Nov; 25(11):1304-1306. PubMed ID: 31401175
    [No Abstract]   [Full Text] [Related]  

  • 36. Prescribers and pharmaceutical representatives: why are we still meeting?
    Fischer MA; Keough ME; Baril JL; Saccoccio L; Mazor KM; Ladd E; Von Worley A; Gurwitz JH
    J Gen Intern Med; 2009 Jul; 24(7):795-801. PubMed ID: 19424764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical commerce, physician entrepreneurialism, and conflicts of interest.
    Rodwin MA
    Camb Q Healthc Ethics; 2007; 16(4):387-97; discussion 439-42. PubMed ID: 18018918
    [No Abstract]   [Full Text] [Related]  

  • 38. How to get full, meaningful disclosure.
    Moynihan R
    Med J Aust; 2011 Nov; 195(10):571. PubMed ID: 22106995
    [No Abstract]   [Full Text] [Related]  

  • 39. After 20 years, industry critics bury skeptics, despite empirical vacuum.
    Barton D; Stossel T; Stell L
    Int J Clin Pract; 2014 Jun; 68(6):666-73. PubMed ID: 24837089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.